1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the...
Warren Buffett, chairman and CEO of Berkshire Hathaway (BRK.B), absolutely adores Apple (
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
More Investing News »